Acorda Therapeutics 10K 2016 Annual report | ACORQ Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: AbbieVie, accommodate, additioanl, adhesion, aid, Alto, amantadine, Amypra, antipsychotic, anxiety, Ascend, assignee, asthma, Auguat, Bayer, BIA, BIAL, bile, Biopharma, Birmingham, borrowing, bronchoconstriction, bypassing, Catherine, CBER, CDER, CDRH, chest, composed, confusion, Connecticut, Council, currency, description, diary, discoloration, discomfort, dispute, dramatically, EBITDA, edition, effectuated, EME, emotional, Euro, eurocurrency, feeling, fine, forum, fourteen, Francisco, Grunenthal, Hakko, heightened, highlighted, hot, inflammatory, input, Intec, irritation, Istradefylline, Japan, Kirin, Kyowa, lab, leader, leaseback, lender, LIBOR, manifested, Medarex, median, memory, Ministry, mistakenly, mode, mood, motivation, mucosa, Newron, noncontrolling, nonexclusive, Opicapone, outlined, outlook, overnight, Overview, Oyj, Palo, particle, pilot, play, Presidential, prime, principle, PTAB, PTE, pursing, reconcile, rental, repay, repeal, rheumatoid, Rituxan, Roche, role, Safinamide, shortly, solving, South, speaking, sputum, Strader, suicide, Sunovian, susceptible, Synosia, taxation, throat, timolumab, Tmax, trailing, transplant, tribunal, true, Turku, UCB, unamortized, underestimating, undivided, unexpectedly, Unfinanced, Unified, unilateral, unreasonably, vascular, venture, vi, vii, viii, vomiting, Waltham, wrote, Zinbryta

Removed: abdomen, abnormality, abnormally, ACC, accident, accretion, age, aged, amifampridine, apprised, artery, ASA, Asian, ATI, baclofen, bearing, billion, bladder, blow, breakthrough, breath, building, buy, Cardiology, Carlo, Carrazana, CDC, chemotherapy, chickenpox, committing, compelling, competitor, comprise, comprising, concept, confer, continuity, coordination, coronary, coughing, creation, de, depriving, deterioration, dietary, diligence, diligent, disagreement, distortion, distributing, dysfunction, dyspnea, earnout, Eaton, edema, educate, EIS, embedded, enhanced, Enrique, enzyme, equaled, EUSA, evaluated, exceeded, excessive, existed, explore, extending, facto, Farmak, fatigue, fit, focal, forelimb, formalization, generalized, George, German, goal, granting, grasping, grown, Guaranty, guide, Hawthorne, headquartered, healed, holdback, Hy, IIA, imbalance, implementing, imputed, indirect, ineffective, inherited, intermediate, intermittent, intramuscular, intranasal, intranasally, joined, Journal, Khayrallah, Lambert, leveraged, lifelong, lifetime, live, Luxembourg, mailing, majeure, male, Mateo, Medtronic, mental, merged, Meridian, Methylprednisolone, midazolam, mix, modest, Moise, Monte, multiparticulate, Myasthenic, naturally, neurologic, Neurotrauma, nominal, nondeductible, North, notifying, NSCISC, ordinary, Orthopedic, outbreak, outlicensed, output, overcoming, packager, PADER, paused, PDN, penalty, persistent, pertained, Pfizer, pharmacologic, PHN, phosphate, pivotal, prefer, prepay, prepayment, proceed, proof, proteoglycan, prove, pump, pumping, rash, recoup, rectally, refractory, rehabilitation, released, renewal, repayable, representative, rest, revaluation, revalued, roughly, Schering, sensation, sensory, sexual, signaling, skin, socially, solicited, somnolence, speaker, spine, stabilize, step, steroid, structure, successive, sum, surviving, swelling, thirty, trauma, unapproved, underserved, vehicle, verbal, verification, vertebrae, video, visual, vitro, vivo, voluntarily, Warsaw, wheezing, wiring, withdrawing

Acorda Therapeutics (ACORQ) 10-K2016 FY Annual report

Content analysis